ID   NCE-G 122
AC   CVCL_N744
SY   NCE G 122; NCE-G122; G-122; G122; NeuroChirurgie Eppendorf-Glioma 122
DR   EFO; EFO_0006400
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03471500
DR   EGA; EGAS00001000610
DR   IARC_TP53; 2145
DR   PharmacoDB; G122_382_2019
DR   Wikidata; Q54907656
RX   PubMed=8253536;
RX   PubMed=8289093;
RX   PubMed=16696057;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*01:01,02:01; B*08:01,15:01; C*03:03,07:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Unexplicit; 10bp deletion in intron4/exon5; Zygosity=Unspecified (PubMed=8253536).
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 12
ST   D21S11: 28
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 13,15
ST   FGA: 22
ST   Penta D: 9,12
ST   Penta E: 7,11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 18
//
RX   PubMed=8253536; DOI=10.1002/ijc.2910550618;
RA   Anker L., Ohgaki H., Ludeke B.I., Herrmann H.-D., Kleihues P.,
RA   Westphal M.;
RT   "p53 protein accumulation and gene mutations in human glioma cell
RT   lines.";
RL   Int. J. Cancer 55:982-987(1993).
//
RX   PubMed=8289093; DOI=10.1007/BF01324703;
RA   Hamel W., Westphal M., Shepard H.M.;
RT   "Loss in expression of the retinoblastoma gene product in human
RT   gliomas is associated with advanced disease.";
RL   J. Neurooncol. 16:159-165(1993).
//
RX   PubMed=16696057; DOI=10.1136/mp.49.2.M91;
RA   Xin L.W., Martinerie C., Zumkeller W., Westphal M., Perbal B.;
RT   "Differential expression of novH and CTGF in human glioma cell
RT   lines.";
RL   Clin. Mol. Pathol. 49:M91-M97(1996).
//
RX   PubMed=25485619; DOI=10.1038/nbt.3080;
RA   Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z.-S.,
RA   Liu H.-B., Degenhardt J., Mayba O., Gnad F., Liu J.-F., Pau G.,
RA   Reeder J., Cao Y., Mukhyala K., Selvaraj S.K., Yu M.-M., Zynda G.J.,
RA   Brauer M.J., Wu T.D., Gentleman R.C., Manning G., Yauch R.L.,
RA   Bourgon R., Stokoe D., Modrusan Z., Neve R.M., de Sauvage F.J.,
RA   Settleman J., Seshagiri S., Zhang Z.-M.;
RT   "A comprehensive transcriptional portrait of human cancer cell
RT   lines.";
RL   Nat. Biotechnol. 33:306-312(2015).
//
RX   PubMed=25877200; DOI=10.1038/nature14397;
RA   Yu M., Selvaraj S.K., Liang-Chu M.M.Y., Aghajani S., Busse M.,
RA   Yuan J., Lee G., Peale F.V., Klijn C., Bourgon R., Kaminker J.S.,
RA   Neve R.M.;
RT   "A resource for cell line authentication, annotation and quality
RT   control.";
RL   Nature 520:307-311(2015).
//
RX   PubMed=26589293; DOI=10.1186/s13073-015-0240-5;
RA   Scholtalbers J., Boegel S., Bukur T., Byl M., Goerges S., Sorn P.,
RA   Loewer M., Sahin U., Castle J.C.;
RT   "TCLP: an online cancer cell line catalogue integrating HLA type,
RT   predicted neo-epitopes, virus and gene expression.";
RL   Genome Med. 7:118.1-118.7(2015).
//